Risk assessment of carcinogenic and noncarcinogenic chemicals.
暂无分享,去创建一个
[1] P. Armitage,et al. Multistage models of carcinogenesis. , 1985, Environmental health perspectives.
[2] A. Heusner. Energy metabolism and body size. I. Is the 0.75 mass exponent of Kleiber's equation a statistical artifact? , 1982, Respiration physiology.
[3] Gio Batta Gori. Regulation of cancer-causing substances: Utopia or reality , 1982 .
[4] H. Druckrey. Quantitative Aspects in Chemical Carcinogenesis , 1967 .
[5] 2-acetylaminofluorene and the Weibull model. , 1981, Food and cosmetics toxicology.
[6] W. Gary Flamm,et al. Role of mathematical models in assessment of risk and in attempts to define management strategy , 1984 .
[7] D. Clayson. ICPEMC publication no. 13 the need for biological risk assessment in reaching decisions about carcinogens (MTR07214) , 1987 .
[8] H. Stokinger. Toxicology and Drinking Water Contaminants , 1977 .
[9] T. Starr,et al. Experimental design constraints on carcinogenic potency estimates. , 1989, Journal of toxicology and environmental health.
[10] I W Davidson,et al. Biological basis for extrapolation across mammalian species. , 1986, Regulatory toxicology and pharmacology : RTP.
[11] F. Lu,et al. Safety assessments of chemicals with thresholded effects. , 1985, Regulatory toxicology and pharmacology : RTP.
[12] S. Moolgavkar. Biologically motivated two-stage model for cancer risk assessment. , 1988, Toxicology letters.
[13] V. Covello. The perception of technological risks: A literature review , 1983 .
[14] E J Freireich,et al. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. , 1966, Cancer chemotherapy reports.
[15] S. Moolgavkar,et al. Biologically based models for cancer risk assessment: a cautionary note. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.
[16] K. Bischoff,et al. Methotrexate pharmacokinetics. , 1971, Journal of pharmaceutical sciences.
[17] D. Barnes,et al. Reference dose (RfD): description and use in health risk assessments. , 1988, Regulatory toxicology and pharmacology : RTP.
[18] Harold Francis Blum,et al. Carcinogenesis by Ultraviolet Light , 1959 .
[19] W. Wieser,et al. A distinction must be made between the ontogeny and the phylogeny of metabolism in order to understand the mass exponent of energy metabolism. , 1984, Respiration physiology.
[20] J. Wahrendorf,et al. Some examples of dose-response studies in chemical carcinogenesis. , 1976, Oncology.
[21] S H Moolgavkar,et al. Mutation and cancer: a model for human carcinogenesis. , 1981, Journal of the National Cancer Institute.
[22] K S Crump. Models for carcinogenic risk assessment. , 1978, Science.
[23] J. Cotruvo. Drinking water standards and risk assessment. , 1988, Regulatory toxicology and pharmacology : RTP.
[24] R. McCauley,et al. The effect of in vivo exposure to diesel exhaust on rat hepatic and pulmonary microsomal activities , 1981, Journal of applied toxicology : JAT.
[25] S. A. Richter,et al. Cancer risk management A review of 132 federal regulatory decisions. , 1987, Environmental science & technology.
[26] D. Hoel. Statistical measures of risk. , 1982, Drug metabolism reviews.
[27] D Hattis,et al. Human variability in susceptibility to toxic chemicals--a preliminary analysis of pharmacokinetic data from normal volunteers. , 1987, Risk analysis : an official publication of the Society for Risk Analysis.
[28] F. Vocci,et al. Extrapolation of animal toxicity data to man. , 1988, Regulatory toxicology and pharmacology : RTP.
[29] Quantitative Risk Assessment: State-of-the-Art for Carcinogenesis , 1983 .
[30] J H Weisburger,et al. Carcinogen testing: current problems and new approaches. , 1981, Science.
[31] S. Salley,et al. Ultrastructure and morphometry of the alveolar lung of guinea pigs chronically exposed to diesel engine exhaust: Six month's experience , 1981, Journal of applied toxicology : JAT.
[32] James G. Wilson. Environment and birth defects , 1973 .
[33] S M Brett,et al. Significant risk decisions in federal regulatory agencies. , 1987, Regulatory toxicology and pharmacology : RTP.
[34] R. Wilson. Measuring and comparing risks to establish a de minimis risk level. , 1988, Regulatory toxicology and pharmacology : RTP.
[35] H. Jones,et al. Analysis of mathematical models used in data extrapolation. , 1976, Clinical toxicology.
[36] K S Crump,et al. Correlation between carcinogenic potency of chemicals in animals and humans. , 1988, Risk Analysis.
[37] Edward J. Calabrese,et al. Principles of animal extrapolation , 1983 .
[38] D J Paustenbach,et al. A physiologically based pharmacokinetic model for 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice. , 1988, Toxicology letters.
[39] Risk estimation for environmental chemicals as a basis for decision making. , 1984, Regulatory toxicology and pharmacology : RTP.
[40] O. G. Fitzhugh,et al. 100-Fold margin of safety , 1954 .
[41] S. Moolgavkar,et al. Two-event models for carcinogenesis: incidence curves for childhood and adult tumors☆ , 1979 .
[42] E. Bingham,et al. Environmental carcinogens. The modifying effect of cocarcinogens on the threshold response. , 1969, Archives of environmental health.
[43] C. Brown. Statistical aspects of extrapolation of dichotomous dose-response data. , 1978, Journal of the National Cancer Institute.
[44] E A Crouch,et al. Uncertainties in interspecies extrapolations of carcinogenicity. , 1983, Environmental health perspectives.
[45] P. Watanabe,et al. RISK ASSESSMENT OF ENVIRONMENTAL CARCINOGENS UTILIZING PHARMACOKINETIC PARAMETERS , 1979 .
[46] J. Mordenti. Dosage regimen design for pharmaceutical studies conducted in animals. , 1986, Journal of pharmaceutical sciences.
[47] B. P. Mcnamara,et al. Concepts in health evaluation of commercial and industrial chemicals , 1975 .
[48] M E Andersen,et al. Physiological model for tissue glutathione depletion and increased resynthesis after ethylene dichloride exposure. , 1988, The Journal of pharmacology and experimental therapeutics.
[49] Elizabeth L. Anderson,et al. Quantitative Approaches in Use to Assess Cancer Risk , 1983 .
[50] K. Crump,et al. Improved confidence limits for low-dose carcinogenic risk assessment from animal data☆ , 1985 .
[51] E M Johnson,et al. Cross-species extrapolations and the biologic basis for safety factor determinations in developmental toxicology. , 1988, Regulatory toxicology and pharmacology : RTP.
[52] H. Guess,et al. Low-dose-rate extrapolation of data from animal carcinogenicity experiments— analysis of a new statistical technique , 1976 .
[53] R. Albert,et al. Considerations relating to the formulation of limits for unavoidable population exposures to environmental carcinogens , 1972 .
[54] J. Tukey,et al. An improved Mantel-Bryan procedure for "safety" testing of carcinogens. , 1975, Cancer research.
[55] O E Paynter,et al. Goitrogens and thyroid follicular cell neoplasia: evidence for a threshold process. , 1988, Regulatory toxicology and pharmacology : RTP.
[56] C. R. Cothern,et al. Estimating risk for carcinogenic environmental contaminants and its impact on regulatory decision making. , 1984, Regulatory toxicology and pharmacology : RTP.
[57] E J Calabrese,et al. Uncertainty factors and interindividual variation. , 1985, Regulatory toxicology and pharmacology : RTP.
[58] E. Anderson,et al. New Risk Assessment Initiatives in Epa , 1985, Toxicology and industrial health.
[59] D G Hoel,et al. Fundamental carcinogenic processes and their implications for low dose risk assessment. , 1976, Cancer research.
[60] P. Armitage,et al. A Two-stage Theory of Carcinogenesis in Relation to the Age Distribution of Human Cancer , 1957, British Journal of Cancer.
[61] Mantel Nathan,et al. Safety" testing of carcinogenic agents. , 1961 .
[62] D. J. Campbell. Drug residues in animal tissues and their regulatory significance--the Canadian point of view. , 1978, Journal - Association of Official Analytical Chemists.
[63] R. Zielhuis,et al. The use of a safety factor in setting health based permissible levels for occupational exposure , 1979, International archives of occupational and environmental health.
[64] J. Cornfield,et al. Carcinogenic risk assessment. , 1977, Science.
[65] P. Slovic. Perception of risk. , 1987, Science.
[66] J Van Ryzin,et al. A generalized multihit dose-response model for low-dose extrapolation. , 1981, Biometrics.
[67] R K Jain,et al. Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.
[68] G. Vettorazzi,et al. SAFETY FACTORS AND THEIR APPLICATION IN THE TOXICOLOGICAL EVALUATION , 1977 .
[69] D Krewski,et al. Determining "safe" levels of exposure: safety factors or mathematical models? , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[70] B. Butterworth,et al. Nongenotoxic carcinogens in the regulatory environment. , 1989, Regulatory toxicology and pharmacology : RTP.
[71] M L Dourson,et al. Regulatory history and experimental support of uncertainty (safety) factors. , 1983, Regulatory toxicology and pharmacology : RTP.
[72] R. Tardiff,et al. Review of interspecies risk comparisons. , 1988, Regulatory toxicology and pharmacology : RTP.
[73] D Krewski,et al. A comparison of statistical methods for low dose extrapolation utilizing time-to-tumor data. , 1983, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[74] Michael R. Taylor,et al. Application of risk assessment to food safety decision making. , 1983, Regulatory toxicology and pharmacology : RTP.
[75] F. A. Denz,et al. Experimental methods used in determining chronic toxicity; a critical review. , 1954, Pharmacological reviews.
[76] D G Hoel,et al. Implication of nonlinear kinetics on risk estimation in carcinogenesis. , 1983, Science.
[77] E J Bigwood,et al. The acceptable daily intake of food additives. , 1973, CRC critical reviews in toxicology.
[78] H. Feldman,et al. The 3/4 mass exponent for energy metabolism is not a statistical artifact. , 1983, Respiration physiology.
[79] K T Bogen,et al. Pharmacokinetics for regulatory risk analysis: the case of trichloroethylene. , 1988, Regulatory toxicology and pharmacology : RTP.
[80] I C Munro,et al. Risk assessment and regulatory decision making. , 1981, Food and cosmetics toxicology.
[81] D. Krewski,et al. Carcinogenic risk assessment: a guide to the literature. , 1981, Biometrics.
[82] D G Hoel,et al. Estimation of risks of irreversible, delayed toxicity. , 1975, Journal of toxicology and environmental health.
[83] Gaylor Dw,et al. Linear interpolation algorithm for low dose risk assessment of toxic substances. , 1980 .
[84] Pike Mc,et al. A method of analysis of a certain class of experiments in carcinogenesis. , 1966 .
[85] Some practical problems arising from use of the gamma multihit model for risk estimation. , 1981, Journal of toxicology and environmental health.
[86] L. Ellwein,et al. Cell growth dynamics in long-term bladder carcinogenesis. , 1988, Toxicology letters.
[87] D. Cox. Regression Models and Life-Tables , 1972 .
[88] B. Ames,et al. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. , 1983, Science.
[89] M E Andersen,et al. Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessment. , 1988, Toxicology letters.
[90] R. Albert,et al. Rationale developed by the Environmental Protection Agency for the assessment of carcinogenic risks. , 1977, Journal of the National Cancer Institute.
[91] D. Pinkel. The use of body surface area as a criterion of drug dosage in cancer chemotherapy. , 1958, Cancer research.
[92] J. Wahrendorf,et al. A dose‐response study on urethane carcinogenesis in rats and mice , 1977, International journal of cancer.
[93] R. Albert,et al. Approaches to the formulation of standards for carcinogenic substances in the environment. , 1979, Environmental health perspectives.
[95] C. I. Bliss. THE CALCULATION OF THE DOSAGE-MORTALITY CURVE , 1935 .
[96] E. O'flaherty. A physiologically based model of skeletal growth in the rat. , 1988, Toxicology letters.
[97] David G. Hoel,et al. Some Tautologous Aspects of the Comparison of Carcinogenic Potency in Rats and Mice , 1985 .
[98] F C Lu. Toxicological evaluations of carcinogens and noncarcinogens: pros and cons of different approaches. , 1983, Regulatory toxicology and pharmacology : RTP.
[99] G. Williams,et al. Carcinogen risk assessment. , 1983, Science.
[100] W J Hayes,et al. Toxicity of pesticides to man: risks from present levels , 1967, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[101] B. Cohen,et al. A catalog of risks. , 1979, Health physics.
[102] F. Lu,et al. Acceptable daily intake: inception, evolution, and application. , 1988, Regulatory toxicology and pharmacology : RTP.
[103] Gross Ma,et al. Evaluation of safety for food additives: An illustration involving the influence of methyl salicylate on rat reproduction. , 1970 .
[104] D G Hoel,et al. A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: example--vinyl chloride. , 1980, Toxicology and applied pharmacology.
[105] W. S. Abbott,et al. A method of computing the effectiveness of an insecticide. 1925. , 1925, Journal of the American Mosquito Control Association.
[106] R L Sielken,et al. Estimation of "safe doses" in carcinogenic experiments. , 1977, Journal of environmental pathology and toxicology.
[107] T. D. Day. Carcinogenic action of cigarette smoke condensate on mouse skin. , 1967, British Journal of Cancer.
[108] C. S. Weil,et al. Safety Evaluation of Chemicals, Relationship between Short-and Long-Term Feeding Studies in Designing an Effective Toxicity Test , 1963 .
[109] R. Lutz,et al. Implications of pharmacokinetic modeling in risk assessment analysis. , 1987, Environmental health perspectives.
[110] H. Guess,et al. Uncertainty estimates for low-dose-rate extrapolations of animal carcinogenicity data. , 1977, Cancer research.
[111] G. Blau,et al. Mechanisms of carcinogenesis: dose response. , 1978, Journal of environmental pathology and toxicology.
[112] L. Fishbein,et al. Overview of some aspects of quantitative risk assessment. , 1980, Journal of toxicology and environmental health.
[113] F. W. Carlborg. Dose-response functions in carcinogenesis and the Weibull model. , 1981, Food and cosmetics toxicology.
[114] R. Zeckhauser,et al. The perils of prudence: how conservative risk assessments distort regulation. , 1988, Regulatory toxicology and pharmacology : RTP.
[115] Crump Ks,et al. Confidence intervals and test of hypotheses concerning dose response relations inferred from animal carcinogenicity data. , 1977 .
[116] P. Lee,et al. Weibull distributions for continuous-carcinogenesis experiments. , 1973, Biometrics.
[117] J. Young,et al. Pharmacokinetics of inhaled styrene in rats and humans. , 1978, Scandinavian journal of work, environment & health.
[118] M. Hogan. Extrapolation of animal carcinogenicity data: limitations and pitfalls. , 1983, Environmental health perspectives.
[119] B. L. Oser,et al. Much ado about safety , 1969 .
[120] V. Frankos. FDA perspectives on the use of teratology data for human risk assessment , 1985 .
[121] D B Menzel,et al. Planning and using PB-PK models: an integrated inhalation and distribution model for nickel. , 1988, Toxicology letters.
[122] P N Lee,et al. Statistical Analysis of the Bio-assay of Continuous Carcinogens , 1972, British Journal of Cancer.
[123] Philip L. Altman,et al. Growth: including reproduction and morphological development. , 1962 .
[124] P. Watanabe,et al. Resolution of dose-response toxicity data for chemicals requiring metabolic activation: example--vinyl chloride. , 1978, Toxicology and applied pharmacology.
[125] M. Cranmer. Estimation of risks due to environmental carcinogenesis. , 1977, Medical and pediatric oncology.
[126] M. Meistrich. Estimation of human reproductive risk from animal studies: determination of interspecies extrapolation factors for steroid hormone effects on the male. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.
[127] C C Travis,et al. Interspecific scaling of toxicity data. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.
[128] J. Young,et al. Pharmacokinetics of inhaled styrene in human volunteers. , 1980, Toxicology and applied pharmacology.
[129] G. Charnley,et al. Biologically motivated cancer risk models. , 1987, Risk analysis : an official publication of the Society for Risk Analysis.
[130] A. Whittemore,et al. Lung cancer incidence in cigarette smokers: further analysis of Doll and Hill's data for British physicians. , 1976, Biometrics.
[131] Edmund A. C. Crouch,et al. Interspecies comparison of carcinogenic potency , 1979 .
[132] C S Weil,et al. Statistics vs safety factors and scientific judgment in the evaluation of safety for man. , 1972, Toxicology and applied pharmacology.
[133] Knut Schmidt-Nielsen,et al. How Animals Work , 1972 .
[134] M E Andersen,et al. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. , 1984, Toxicology and applied pharmacology.
[135] D. Rall,et al. Difficulties in extrapolating the results of toxicity studies in laboratory animals to man. , 1969, Environmental research.
[136] L S Birnbaum,et al. Physiological model for the pharmacokinetics of 2,3,7,8-tetrachlorodibenzofuran in several species. , 1983, Toxicology and applied pharmacology.
[137] R. Truhaut. An overview of the problem of thresholds for chemical carcinogens. , 1979, IARC scientific publications.